• Diversified product portfolio further with the introduction of wide range of Cephalosporins (Oral & Sterile) and anti – virals in addition to macrolides, anti-ulcerants, quinolones, semi-synthetic penicillins, and formulations for domestic and export market.
  • Joint Ventures launched for formulations business in US.
  • Sri Chakra Remedies Ltd was amalgamated with the company.